Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.
The hormone, relaxin, inhibits aberrant myofibroblast differentiation and collagen deposition by disrupting the TGF-β1/Smad2 axis, via its cognate receptor, Relaxin Family Peptide Receptor 1 (RXFP1), extracellular signal-regulated kinase (ERK)1/2 phosphorylation (pERK) and a neuronal nitric oxide (N...
Guardado en:
Autores principales: | Bryna Suet Man Chow, Elaine Guo Yan Chew, Chongxin Zhao, Ross A D Bathgate, Tim D Hewitson, Chrishan S Samuel |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea568fb76cec4ff18ac4e09026c96529 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
por: Martina Kocan, et al.
Publicado: (2017) -
The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1
por: Ashish Sethi, et al.
Publicado: (2016) -
Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO
por: Khosrow Kashfi, et al.
Publicado: (2021) -
Automated computational analysis reveals structural changes in the enteric nervous system of nNOS deficient mice
por: Ben R. Cairns, et al.
Publicado: (2021) -
Salvia fruticosa Induces Vasorelaxation In Rat Isolated Thoracic Aorta: Role of the PI3K/Akt/eNOS/NO/cGMP Signaling Pathway
por: M. Akhtar Anwar, et al.
Publicado: (2017)